| Cell line name |
RPMI-8226/Dox6 |
|---|
| Synonyms |
RPMI 8226/DOX6; 8226/DOX6; 8226/Dox6; DOX-6; Dox6 |
|---|
| Accession |
CVCL_J432 |
|---|
| Resource Identification Initiative |
To cite this cell line use: RPMI-8226/Dox6 (RRID:CVCL_J432) |
|---|
| Comments |
Population: African American.
Characteristics: Produces IgG lambda (from parent cell line).
Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Cell type: B-cell; CL=CL_0000236. |
|---|
| Sequence variations |
- Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
- Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
- Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
|
|---|
| Disease |
Plasma cell myeloma (NCIt: C3242)
Multiple myeloma (ORDO: Orphanet_29073) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_0014 (RPMI-8226) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
61Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=2569359
Tong A.W., Lee J., Wang R.-M., Dalton W.S., Tsuruo T., Fay J.W., Stone M.J.
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
Cancer Res. 49:4829-4834(1989) PubMed=10070958
Hazlehurst L.A., Foley N.E., Gleason-Guzman M.C., Hacker M.P., Cress A.E., Greenberger L.M., de Jong M.C., Dalton W.S.
Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.
Cancer Res. 59:1021-1028(1999) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_J432
|
|---|
| Encyclopedic resources |
Wikidata; Q54951247
|
|---|
| Entry history |
|---|
| Entry creation | 11-Feb-2013 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 19 |
|---|
